Discovery and development of new medicines to treat severe diseases of the central nervous system.

Founded in Barcelona in 2020, the company is developing innovative medicines to treat patients suffering from central nervous system diseases. The current assets target Acute Optic Neuritis, Multiple Sclerosis, Parkinson and Epilepsy.

Fund

Alta Life Sciences Spain I FCR

Sector

Therapeutics

Website

Exit year